Cargando…
Forecasting Cholesterol Management-End of the Statin Gold Rush?
For the last 15 years or more, lowering the low-density lipoprotein (LDL) component of total serum cholesterol has been the principal focus in cholesterol management. Ever more powerful HMG CoA reductase inhibitors (statins) captured attention in their ability to lower LDL cholesterol (LDL-C). Simva...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438089/ https://www.ncbi.nlm.nih.gov/pubmed/16925456 http://dx.doi.org/10.18553/jmcp.2006.12.6.479 |